{"id":"https://openalex.org/W2050375141","doi":"https://doi.org/10.1097/00008571-199512001-00009","title":"The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors","display_name":"The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors","publication_year":1995,"publication_date":"1995-12-01","ids":{"openalex":"https://openalex.org/W2050375141","doi":"https://doi.org/10.1097/00008571-199512001-00009","mag":"2050375141","pmid":"https://pubmed.ncbi.nlm.nih.gov/7581498"},"language":"en","primary_location":{"id":"doi:10.1097/00008571-199512001-00009","doi":"https://doi.org/10.1097/00008571-199512001-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-199512001-00009","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110054479","display_name":"Robert A. Branch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R A Branch","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh, PA 15261, USA","Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh, PA 15261, USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111367384","display_name":"H D Chern","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H D Chern","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113733109","display_name":"Adedayo B. Adedoyin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Adedoyin","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020781314","display_name":"M Romkes-Sparks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Romkes-Sparks","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057493616","display_name":"Timothy G. Lesnick","orcid":"https://orcid.org/0000-0002-4126-5924","observed_orcids":["https://orcid.org/0000-0002-4126-5924"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T G Lesnick","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh, Scaife Hall/Room 623, Pittsburgh, PA 15261, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034333092","display_name":"R A Persad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R Persad","raw_affiliation_strings":["Addenbrooks Hospital, Department of Urology, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addenbrooks Hospital, Department of Urology, Cambridge, UK","institution_ids":["https://openalex.org/I4210156194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015414548","display_name":"Grant R. Wilkinson","orcid":"https://orcid.org/0000-0001-9701-3016","observed_orcids":["https://orcid.org/0000-0001-9701-3016"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G R Wilkinson","raw_affiliation_strings":["Vanderbilt University, Division of Clinical Pharmacology, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Division of Clinical Pharmacology, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112099569","display_name":"C. Fleming","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C M Fleming","raw_affiliation_strings":["Vanderbilt University, Division of Clinical Pharmacology, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Division of Clinical Pharmacology, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110304126","display_name":"Anthony Dickinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A J Dickinson","raw_affiliation_strings":["University of Bristol, Department of Urology, Bristol, Avon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bristol, Department of Urology, Bristol, Avon, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":null,"display_name":"G Sibley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G Sibley","raw_affiliation_strings":["University of Bristol, Department of Urology, Bristol, Avon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bristol, Department of Urology, Bristol, Avon, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"last","author":{"id":null,"display_name":"P Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P Smith","raw_affiliation_strings":["University of Bristol, Department of Urology, Bristol, Avon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bristol, Department of Urology, Bristol, Avon, UK","institution_ids":["https://openalex.org/I36234482"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3293,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.77399849,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"5","issue":"Special Issue","first_page":"S97","last_page":"S102"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12187","display_name":"Glutathione Transferases and Polymorphisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/drug-metabolizing-enzymes","display_name":"drug-metabolizing enzymes","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.8849999904632568},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":1.0},{"id":"https://openalex.org/keywords/mephenytoin","display_name":"mephenytoin","score":0.8560000061988831},{"id":"https://openalex.org/keywords/debrisoquine","display_name":"debrisoquine","score":0.996999979019165},{"id":"https://openalex.org/keywords/dapsone","display_name":"dapsone","score":0.9919999837875366},{"id":"https://openalex.org/keywords/alcohol-consumption","display_name":"alcohol consumption","score":0.6010000109672546},{"id":"https://openalex.org/keywords/metabolic-activation","display_name":"metabolic activation","score":0.375}],"concepts":[{"id":"https://openalex.org/C114246631","wikidata":"https://www.wikidata.org/wiki/Q187661","display_name":"Carcinogen","level":2,"score":0.7813402414321899},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.7153699994087219},{"id":"https://openalex.org/C2776838488","wikidata":"https://www.wikidata.org/wiki/Q1175385","display_name":"Mephenytoin","level":5,"score":0.686634361743927},{"id":"https://openalex.org/C2777600422","wikidata":"https://www.wikidata.org/wiki/Q3704421","display_name":"Debrisoquine","level":5,"score":0.6840410232543945},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5375933051109314},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5020356178283691},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.43997105956077576},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.3901345133781433},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3618927001953125},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3618786334991455},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2720704674720764},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.13768330216407776},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10302495956420898}],"mesh":[{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D002273","descriptor_name":"Carcinogens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008658","descriptor_name":"Inactivation, Metabolic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00008571-199512001-00009","doi":"https://doi.org/10.1097/00008571-199512001-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-199512001-00009","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},{"id":"pmid:7581498","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7581498","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G7982882065","display_name":"DETERMINANTS  OF INDIVIDUAL RESPONSIVENESS TO DRUGS","funder_award_id":"P01GM031304","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G8392819876","display_name":"DRUG METABOLIZING ENZYMES-RISK FACTORS IN BLADDER CANCER","funder_award_id":"R01CA059834","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2059398536","https://openalex.org/W2113509113","https://openalex.org/W7095547477","https://openalex.org/W2008643787","https://openalex.org/W2125654458","https://openalex.org/W1992969217","https://openalex.org/W4391733052","https://openalex.org/W3032392411","https://openalex.org/W1964847747","https://openalex.org/W1999265683"],"abstract_inverted_index":{"Bladder":[0],"cancer":[1,34,151,162,209],"provides":[2],"the":[3,17,23,30,59,67,69,72,101,119,124,139,203,224],"most":[4],"definitive":[5],"example":[6],"for":[7,100,207],"an":[8,172],"association":[9],"between":[10],"environmental":[11,40,205],"agents":[12],"and":[13,29,95,109,118,152,210],"cancer.":[14,241],"However,":[15],"in":[16,33,75,129,143,183,190,223],"absence":[18],"of":[19,43,64,71,78,83,104,106,115,121,147,168,174,177,199,214,216,226,238],"industrial":[20],"occupational":[21],"exposure,":[22],"primary":[24],"carcinogen":[25],"is":[26],"rarely":[27],"identified,":[28],"mechanisms":[31],"involved":[32,74,222],"formation":[35,77],"are":[36,127],"poorly":[37],"understood.":[38],"The":[39],"procarcinogen":[41,204],"hypothesis":[42,206],"tumour":[44,88,228],"pathogenesis":[45,225],"proposes":[46],"that":[47,212],"many":[48],"carcinogens":[49],"require":[50],"metabolic":[51],"activation":[52],"by":[53],"drug":[54,141,200,219],"metabolizing":[55,220],"enzymes":[56,73,221],"to":[57,66,232],"form":[58],"proximate":[60,79],"carcinogen.":[61],"A":[62],"balance":[63],"exposure":[65],"carcinogen,":[68,80],"activity":[70,105,215],"either":[76],"or":[81],"production":[82],"non-toxic":[84],"metabolites,":[85],"will":[86],"determine":[87],"risk.":[89],"We":[90,136],"have":[91,133,137],"used":[92,231],"mephenytoin,":[93],"debrisoquine":[94],"dapsone":[96,184],"as":[97],"selective":[98],"probes":[99],"phenotypic":[102,116],"measures":[103],"CYP2C19,":[107],"CYP2D6,":[108],"CYP3A4,":[110],"respectively.":[111],"Within":[112],"subject":[113],"reproducibility":[114],"measures,":[117],"lack":[120],"cross-inhibition":[122],"when":[123],"three":[125],"drugs":[126],"given":[128],"a":[130,166,179],"concurrent":[131],"cocktail,":[132],"been":[134],"confirmed.":[135],"applied":[138],"cocktail":[140],"approach":[142],"two,":[144],"non-overlapping":[145],"series":[146],"cases":[148],"with":[149,159],"bladder":[150,161,208,240],"matched":[153],"controls.":[154],"In":[155],"both":[156],"series,":[157],"patients":[158],"aggressive":[160],"(GIII":[163],"histopathology)":[164],"had":[165],"history":[167],"excess":[169],"alcohol":[170],"intake,":[171],"under-representation":[173],"poor":[175],"metabolizers":[176],"debrisoquine,":[178],"significant":[180],"mean":[181],"reduction":[182],"recovery":[185],"ratio,":[186],"but":[187],"no":[188],"difference":[189],"mephenytoin":[191],"phenotype.":[192],"Collectively,":[193],"these":[194],"observations":[195],"involving":[196],"multiple":[197],"routes":[198],"metabolism":[201],"support":[202],"suggest":[211],"measurement":[213],"selected":[217],"individual":[218],"this":[227],"can":[229],"be":[230],"identify":[233],"subjects":[234],"at":[235],"high":[236],"risk":[237],"developing":[239]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}